There is no doubting their convenience both to the physician and to the patient for quick, easy venous access for any purpose. They are of particular value if the patient is an infant or young child who requires intensive chemotherapy for malignant disease. Infective complications constitute the most serious risk in the immunosuppressed patient and several workers35 have documented a higher incidence of infection by coagulase negative staphylococci ('Staphylococcus albus') after use of these catheters.
We analyse our first three years of experience with these catheters in the haematology/oncology unit at Bristol Children's Hospital. In particular, episodes of catheter related bacteraemia (often with multiple bacterial strains) are presented and risk factors, prognosis, and management are discussed.
Patients and methods
Patients, catheter insertion and care. Hickman and Broviac catheters have been in regular use in this unit since 1981. They have all been inserted under general anaesthetic by one surgeon. All were placed in the superior vena cava or right atrium-usually via the external jugular vein; rarely via the cephalic or internal jugular veins. All were tunnelled to an exit site on the anterior chest wall medial to the nipple. The type of catheter inserted depended mainly on the size of the child; Broviac catheters were used in infants and young children, and the larger Hickman catheters in older children.
Three groups of patients were selected as most likely to benefit from central venous access of this type. These were:
(a) Children under 2 years of age who required chemotherapy.
(b) Children over 2 years of age who were to receive very intensive chemotherapy.
(c) Children who were experiencing particular psychological difficulties with injections and chemotherapy. Primary induction therapy of acute lymphoblastic leukaemia was not in itself regarded as an indication for catheter placement at any age.
After consultation with the patient and parents, most catheters were inserted early in the course of treatment, usually within the first week. All catheters received similar care from a small group of nurses. After the initial postoperative period a new non-occlusive dressing was applied to the insertion site each week; no antibiotic preparations were applied. In both inpatients and outpatients the 129 catheter, when not in use, was flushed twice daily with 5 ml of heparin solution (10 U/ml Hepsal, Weddel). Any procedure involving use of the catheter was performed with sterile precautions, and the catheter was flushed with the heparin solution after use of any kind. Before the patient was discharged from hospital, one parent had to satisfy the nursing team of his or her competence in care of the catheter.
As patients received all treatment through the catheter-blood sampling, chemotherapy, intravenous fluids, blood products, and intravenous feeding-the catheters often received heavy use, particularly in the early weeks of treatment. The 
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9 (1) 10 (1) 11 (1) 12 (1) 13 (1) 14 (1) (2) (1) (2) 15 (3) (4) The use of the catheters was assessed by the criteria defined in the Methods section. In the week preceding the 29 catheter related bacteraemias, the catheter had been subjected to type 3 use in 17 cases, whereas most catheter use was of types 1 and 2. There was an overall incidence of 0-68 episodes of catheter related bacteraemia per 100 days of catheter use, and 44% of patients had one or more episodes of bacteraemia related to the catheter.
The reasons for removal of the catheters are given in Table 3 . Over 20% of catheters were removed because of malposition, breakage, thrombosis, and even on two occasions accidental removal by the patients, while only four catheters were removed because of failure to eradicate infection, a further two being removed before the results of antimicrobial treatment were assessable. No serious incidents occurred among outpatients with indwelling catheters. In general the care given to the catheters by the patients and parents at home was good. No child with an indwelling central venous catheter in situ died of infection but four deaths have occurred in the patients described, all due to progressive disease.
All four children in whom the catheter was placed 13 in 17 bacteraemic episodes in children without indwelling central venous catheters coagulase negative staphylococci were isolated in only one patient. This suggests strongly that while some of the non-coagulase negative staphylococcal organisms may be unrelated to the catheter, the increased incidence of coagulase negative staphylococcal infection in our catheterised patients is directly related to the catheters. Other authors disagreed and suggest that granulocytopenia predisposes to coagulase negative staphylococcal infection, but this is not supported by our findings. The propensity of coagulase negative staphylococci to colonise plastic surfaces and to resist the antibacterial activity of the blood has been reported by many workers.'5l7 Nine episodes of bacteraemia yielded multiple (up to six) isolates, not only of different species but of different strains of the same species, whether coagulase negative staphylococci or other bacteria. The criteria used to separate the strains are not absolute, but together the results clearly indicate contemporaneous colonisation by multiple strains. Indeed the difficulty of first recognising variations within the growth on the culture plates, and the fact that this aspect was investigated retrospectively on isolates selected for laboratory preservation, suggest that we have underestimated the heterogeneity of the bacterial growth, and that very discriminating examination of cultures in these patients is essential.
The results presented show clearly that bacteraemia occurring in patients with indwelling central venous catheters can be eradicated in most-in this series 72%. Obviously the risks of prolonged antibiotic treatment-possible emergence of resistant bacteria and fungal overgrowth-must be considered as well as other as yet theoretical problems such as immune complex nephritis. There is little point in subjecting a child to these risks if the catheter has reached the end of its period of maximum use, hence decisions on removal must be made on an individual basis. We now regard mixed infection as a more difficult problem and consider removal earlier in these circumstances.
While we have emphasised the infections and other complications seen during our first three years' use of these catheters, the positive aspects are more difficult to quantify. The complications have, in most cases, been readily manageable and both doctors and patients would prefer not to go back to peripheral venepunctures. Our criteria for insertion of indwelling central venous catheters have not changed after analysis of these data, but we do not think that a wider use of these catheters is indicated. The risk of catheter related bacteraemia is high (16 of 36 patients) but eradication of infection is possible without removing the catheter. We suggest that careful appraisal of the benefits and risks in individual patients is mandatory if these catheters are to be used to optimal benefit in a paediatric oncology population.
